A fusion peptide in preS1 and the human protein-disulfide isomerase ERp57 are involved in HBV membrane fusion process

  1. Jimena Pérez-Vargas
  2. Elin Teppa
  3. Fouzia Amirache
  4. Bertrand Boson
  5. Rémi Pereira de Oliveira
  6. Christophe Combet
  7. Anja Böckmann
  8. Floriane Fusil
  9. Natalia Freitas  Is a corresponding author
  10. Alessandra Carbone  Is a corresponding author
  11. François-Loïc Cosset  Is a corresponding author
  1. École normale supérieure de Lyon, France
  2. Sorbonne Université, France
  3. Centre International de Recherche en Infectiologie, France
  4. Cancer Research Center of Lyon (CRCL), France
  5. University of Lyon, France
  6. Sorbonne Universités, UPMC Univ. Paris 06, France

Abstract

Cell entry of enveloped viruses relies on the fusion between the viral and plasma or endosomal membranes, through a mechanism that is triggered by a cellular signal. Here we used a combination of computational and experimental approaches to unravel the main determinants of hepatitis B virus (HBV) membrane fusion process. We discovered that ERp57 is a host factor critically involved in triggering HBV fusion and infection. Then, through modelling approaches, we uncovered a putative allosteric cross-strand disulfide (CSD) bond in the HBV S glycoprotein and we demonstrate that its stabilization could prevent membrane fusion. Finally, we identified and characterized a potential fusion peptide in the preS1 domain of the HBV L glycoprotein. These results underscore a membrane fusion mechanism that could be triggered by ERp57, allowing a thiol/disulfide exchange reaction to occur and regulate isomerization of a critical CSD, which ultimately leads to the exposition of the fusion peptide.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for figures 1-3, 5-7 and 9.

Article and author information

Author details

  1. Jimena Pérez-Vargas

    École normale supérieure de Lyon, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Elin Teppa

    UMR 7238, Biologie Computationnelle et Quantitative, Sorbonne Université, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Fouzia Amirache

    École normale supérieure de Lyon, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Bertrand Boson

    Centre International de Recherche en Infectiologie, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Rémi Pereira de Oliveira

    École normale supérieure de Lyon, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Christophe Combet

    U1052, Cancer Research Center of Lyon (CRCL), Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7348-3520
  7. Anja Böckmann

    Molecular Microbiology and Structural Biochemistry, University of Lyon, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8149-7941
  8. Floriane Fusil

    École normale supérieure de Lyon, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Natalia Freitas

    École normale supérieure de Lyon, Lyon, France
    For correspondence
    natalia.bezerra-de-freitas@ens-lyon.fr
    Competing interests
    The authors declare that no competing interests exist.
  10. Alessandra Carbone

    UMR 7238, Biologie Computationnelle et Quantitative, Sorbonne Universités, UPMC Univ. Paris 06, Paris, France
    For correspondence
    Alessandra.Carbone@lip6.fr
    Competing interests
    The authors declare that no competing interests exist.
  11. François-Loïc Cosset

    École normale supérieure de Lyon, Lyon, France
    For correspondence
    flcosset@ens-lyon.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8842-3726

Funding

ANRS (ECTZ160643)

  • François-Loïc Cosset

ANR (ANR-11-LABX-0048)

  • François-Loïc Cosset

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were performed in accordance with the European Union guidelines for approval of the protocols by the local ethics committee (Authorization Agreement C2EA-15, "Comité Rhône-Alpes d'Ethique pour l'Expérimentation Animale", Lyon, France - APAFIS#27316-2020060810332115 v4).

Reviewing Editor

  1. Mark Marsh, University College London, United Kingdom

Version history

  1. Received: October 31, 2020
  2. Accepted: June 29, 2021
  3. Accepted Manuscript published: June 30, 2021 (version 1)
  4. Version of Record published: July 15, 2021 (version 2)

Copyright

© 2021, Pérez-Vargas et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,615
    Page views
  • 288
    Downloads
  • 10
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jimena Pérez-Vargas
  2. Elin Teppa
  3. Fouzia Amirache
  4. Bertrand Boson
  5. Rémi Pereira de Oliveira
  6. Christophe Combet
  7. Anja Böckmann
  8. Floriane Fusil
  9. Natalia Freitas
  10. Alessandra Carbone
  11. François-Loïc Cosset
(2021)
A fusion peptide in preS1 and the human protein-disulfide isomerase ERp57 are involved in HBV membrane fusion process
eLife 10:e64507.
https://doi.org/10.7554/eLife.64507

Further reading

    1. Computational and Systems Biology
    2. Physics of Living Systems
    Jennifer K Briggs, Anne Gresch ... Richard KP Benninger
    Research Article

    Diabetes is caused by the inability of electrically coupled, functionally heterogeneous -cells within the pancreatic islet to provide adequate insulin secretion. Functional networks have been used to represent synchronized oscillatory [Ca2+] dynamics and to study -cell subpopulations, which play an important role in driving islet function. The mechanism by which highly synchronized -cell subpopulations drive islet function is unclear. We used experimental and computational techniques to investigate the relationship between functional networks, structural (gap-junction) networks, and intrinsic -cell dynamics in slow and fast oscillating islets. Highly synchronized subpopulations in the functional network were differentiated by intrinsic dynamics, including metabolic activity and KATP channel conductance, more than structural coupling. Consistent with this, intrinsic dynamics were more predictive of high synchronization in the islet functional network as compared to high levels of structural coupling. Finally, dysfunction of gap junctions, which can occur in diabetes, caused decreases in the efficiency and clustering of the functional network. These results indicate that intrinsic dynamics rather than structure drive connections in the functional network and highly synchronized subpopulations, but gap junctions are still essential for overall network efficiency. These findings deepen our interpretation of functional networks and the formation of functional sub-populations in dynamic tissues such as the islet.

    1. Computational and Systems Biology
    2. Immunology and Inflammation
    David J Torres, Paulus Mrass ... Judy L Cannon
    Research Article Updated

    T cells are required to clear infection, and T cell motion plays a role in how quickly a T cell finds its target, from initial naive T cell activation by a dendritic cell to interaction with target cells in infected tissue. To better understand how different tissue environments affect T cell motility, we compared multiple features of T cell motion including speed, persistence, turning angle, directionality, and confinement of T cells moving in multiple murine tissues using microscopy. We quantitatively analyzed naive T cell motility within the lymph node and compared motility parameters with activated CD8 T cells moving within the villi of small intestine and lung under different activation conditions. Our motility analysis found that while the speeds and the overall displacement of T cells vary within all tissues analyzed, T cells in all tissues tended to persist at the same speed. Interestingly, we found that T cells in the lung show a marked population of T cells turning at close to 180o, while T cells in lymph nodes and villi do not exhibit this “reversing” movement. T cells in the lung also showed significantly decreased meandering ratios and increased confinement compared to T cells in lymph nodes and villi. These differences in motility patterns led to a decrease in the total volume scanned by T cells in lung compared to T cells in lymph node and villi. These results suggest that the tissue environment in which T cells move can impact the type of motility and ultimately, the efficiency of T cell search for target cells within specialized tissues such as the lung.